Clinical trial
Real-World Study of Hematoporphyrin Injection-Based Photodynamic Therapy in Patients With Recurrent or Residual Superficial Esophageal Cancer
NCT06437288 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Study of Hematoporphyrin Injection-Based Photodynamic Therapy in Patients With Recurrent or Residual Superficial Esophageal Cancer
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- September 18, 2024
- Completion date
- December 1, 2030
- Enrollment
- 198 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer, photodynamic therapy